Literature DB >> 1987376

Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion.

T Morrison1, C McQuain, L McGinnes.   

Abstract

The cDNA derived from the fusion gene of the virulent AV strain of Newcastle disease virus (NDV) was expressed in chicken embryo cells by using a retrovirus vector. The fusion protein expressed in this system was transported to the cell surface and was efficiently cleaved into the disulfide-linked F1-F2 form found in infectious virions. The cells expressing the fusion gene grew normally and could be passaged many times. Monolayers of these cells would plaque, in the absence of trypsin, avirulent NDV strains (strains which encode a fusion protein which is not cleaved in tissue culture). Fusion protein-expressing cells would not fuse if mixed with uninfected cells or uninfected cells expressing the hemagglutinin-neuraminidase (HN) protein. However, the fusion protein-expressing cells, if infected with avirulent strains of NDV, would fuse with uninfected cells, suggesting that fusion requires both the fusion protein and another viral protein expressed in the same cell. Fusion was also seen after transfection of the HN protein gene into fusion protein-expressing cells. Thus, the expressed fusion protein gene is capable of complementing the virus infection, providing an active cleaved fusion protein required for the spread of infection. However, the fusion protein does not mediate cell fusion unless the cell also expresses the HN protein. Fusion protein-expressing cells would not plaque influenza virus in the absence of trypsin, nor would influenza virus-infected fusion protein-expressing cells fuse with uninfected cells. Thus, the influenza virus HA protein will not substitute for the NDV HN protein in cell-to-cell fusion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987376      PMCID: PMC239821     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  The use of circular dichroism to study conformational changes induced in Sendai virus envelope glycoproteins. A correlation with the viral fusogenic activity.

Authors:  V Citovsky; P Yanai; A Loyter
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

2.  Conformational changes in Newcastle disease virus fusion glycoprotein during intracellular transport.

Authors:  L W McGinnes; A Semerjian; T Morrison
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

3.  Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus.

Authors:  M A Bratt; W R Gallaher
Journal:  Proc Natl Acad Sci U S A       Date:  1969-10       Impact factor: 11.205

4.  Mutation of a termination codon affects src initiation.

Authors:  S Hughes; K Mellstrom; E Kosik; F Tamanoi; J Brugge
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

5.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

6.  New procedure for DNA transfection with polycation and dimethyl sulfoxide.

Authors:  S Kawai; M Nishizawa
Journal:  Mol Cell Biol       Date:  1984-06       Impact factor: 4.272

7.  Intracellular processing of the Newcastle disease virus fusion glycoprotein.

Authors:  T Morrison; L J Ward; A Semerjian
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

8.  Preparation and characterization of F-protein vesicles isolated from Sendai virus by means of octyl glucoside.

Authors:  O Sechoy; J R Philippot; A Bienvenue
Journal:  Biochim Biophys Acta       Date:  1986-05-09

9.  Construction of fusogenic vesicles bearing specific antibodies. Targeting of reconstituted Sendai virus envelopes towards neuraminidase-treated human erythrocytes.

Authors:  A G Gitman; A Loyter
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

10.  Membrane-bound antiviral antibodies as receptors for Sendai virions in receptor-depleted erythrocytes.

Authors:  O Nussbaum; N Zakai; A Loyter
Journal:  Virology       Date:  1984-10-30       Impact factor: 3.616

View more
  46 in total

1.  Intracellular processing of the paramyxovirus F protein: critical role of the predicted amphipathic alpha helix adjacent to the fusion domain.

Authors:  C Wang; G Raghu; T Morrison; M E Peeples
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia.

Authors:  C M Horvath; R G Paterson; M A Shaughnessy; R Wood; R A Lamb
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  Analysis of the fusion protein gene of the porcine rubulavirus LPMV: comparative analysis of paramyxovirus F proteins.

Authors:  M Berg; A C Bergvall; M Svenda; A Sundqvist; J Moreno-López; T Linné
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

4.  Transfection of Sendai virus F gene cDNA with mutations at its cleavage site and HN gene cDNA into COS cells induces cell fusion.

Authors:  H Taira; T Sato; H Segawa; M Chiba; T Katsumata; K Iwasaki
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

5.  Fusion activation by a headless parainfluenza virus 5 hemagglutinin-neuraminidase stalk suggests a modular mechanism for triggering.

Authors:  Sayantan Bose; Aarohi Zokarkar; Brett D Welch; George P Leser; Theodore S Jardetzky; Robert A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

6.  Interacting domains of the HN and F proteins of newcastle disease virus.

Authors:  Kathryn A Gravel; Trudy G Morrison
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus.

Authors:  S Bagai; R A Lamb
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  gp120-independent fusion mediated by the human immunodeficiency virus type 1 gp41 envelope glycoprotein: a reassessment.

Authors:  L Marcon; J Sodroski
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Fusion regulation proteins on the cell surface: isolation and characterization of monoclonal antibodies which enhance giant polykaryocyte formation in Newcastle disease virus-infected cell lines of human origin.

Authors:  Y Ito; H Komada; S Kusagawa; M Tsurudome; H Matsumura; M Kawano; H Ohta; M Nishio
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  Single event recording shows that docking onto receptor alters the kinetics of membrane fusion mediated by influenza hemagglutinin.

Authors:  W D Niles; F S Cohen
Journal:  Biophys J       Date:  1993-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.